Massimo Volpe, MD
Disclosure: Massimo Volpe, MD, has disclosed that he has
received honoraria for scientific presentations at meetings as well as for participation in advisory boards by Bayer, Boehringer Ingelheim, Merck and Co., Novartis, sanofi-aventis, and Bristol-Myers Squibb. Dr. Volpe has also disclosed that he has received a research grant from Pfizer.
Désirée Lie, MD, MSEd
Disclosure: Désirée Lie, MD, MSEd, has disclosed no relevant financial
relationships.
Carol Peckham
Disclosure: Carol Peckham has disclosed no relevant financial relationships.
Graham Jackson, MD, FESC, FRCP, FACC
Disclosure: Graham Jackson, MD, FESC, FRCP, FACC, has disclosed that he is an academic advisor to Pfizer, Lilly, Plethora, Shire, and Servier. Dr. Jackson is also the chairman of Sexual Dysfunction Association.
Leslie Citrome, MD, MPH
Disclosure: Leslie Citrome, MD, MPH, has disclosed that he is consultant for, has received honoraria from, or has conducted clinical research supported by Abbott, AstraZeneca, Avanir, Azur, Barr, Bristol-Myers Squibb, Eli Lilly, Forest Research Institute, GlaxoSmithKline, Janssen, Jazz, Pfizer, and Vanda.
Karen Costenbader, MD, MPH
Disclosure: Karen Costenbader, MD, MPH, has disclosed no relevant financial relationships.
Serge Jabbour, MD
Disclosure: Serge Jabbour, MD, has disclosed that he is on the speaker's bureau for Amylin and Eli Lilly.
Rubin Minhas, MB, ChB
Disclosure: Rubin Minhas, MB, ChB, has disclosed no relevant financial relationships.
Matt Rosenberg, MD, BA
Disclosure: Matt Rosenberg, MD, BA, has disclosed that he is a consultant for or received fees for non-CME services from Abbott, Allergan, Astellas, Esprit Pharma, GlaxoSmithKline, Novartis, Ortho-McNeil, Pfizer, Roche, Sanofi-Aventis, and Verathon. Dr. Rosenberg has conducted research funded by sanofi-aventis.
Jagdish Sharma, FRCP
Disclosure: Jagdish
Sharma, FRCP, has disclosed no relevant financial relationships.
Anthony Wierzbicki, FACA, FACB
Disclosure: Anthony Wierzbicki, FACA, FACB, has disclosed that he has received support for travel or lecture honoraria from Abbott, AstraZeneca, Bristol-Myers Squibb, Genzyme, Gilead, Merck KGaA, Merck, Sharp & Dohme, Pfizer, Roche, Schering-Plough, and Solvay Fournier. Dr. Wierzbicki is an advisory board member for
Abbott, AstraZeneca, Bristol-Myers Squibb, Genzyme, Gilead, Kowa, LifeCyclePharma, Merck KGaA, Merck, Sharp & Dohme, Pfizer, Roche, Schering-Plough, Solvay Fournier, Surface Logix, and Takeda.
